Skip to main content
See every side of every news story
Published • loading... • Updated

Hope for Patients: the EU Approved a New Drug Against the Deadliest Form of Cancer

Summary by Teleskop
The European Commission has approved Rasonque, a new medicine for adults whose pancreatic cancer has spread to other parts of the body. This gives them a new treatment option with a previously limited choice of treatments. The medicine is taken once a day as a tablet and is intended for patients who have already received at least one cancer treatment. The same medicine was previously approved in August...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

6 Articles

The European Commission has authorised the marketing of Daraxonrasib in the European Union. The medicinal product is intended for adults with metastatic pancreatic cancer who have already received at least one previous treatment line.

·Portugal
Read Full Article

(Adnkronos) - EU's green light on the drug of hope against metastatic pancreatic cancer. "The European Commission (Ce) approved Rasonque (daraxonrasib) for the treatment of adult patients with adenocarcinoma...

Read Full Article

Final green light for the U.S. drug that increases survival by 6 months (on average) for patients with metastatic pancreatic cancer. Uncognized relapse on Lombardy, had bought it for one patient only

The European Commission has authorised the use of a new medicine for the treatment of metastatic pancreatic cancer in adults who have already undergone previous treatments, according to official announcement.

·Portugal
Read Full Article

The approval is valid in the European Union countries as well as in Iceland, Norway and Liechtenstein. Availability will depend on national decisions on pricing and coverage of treatment costs.

The European Commission has approved Rasonque, a new medicine for adults whose pancreatic cancer has spread to other parts of the body. This gives them a new treatment option with a previously limited choice of treatments. The medicine is taken once a day as a tablet and is intended for patients who have already received at least one cancer treatment. The same medicine was previously approved in August...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Teleskop broke the news on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal